SCHEMBL821076

SCHEMBL821076

COC(=O)C/C=C\CC(=O)OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.53
HSD17B10 Q99714 2/20 0.48
MGAM O43451 1/20 0.48
GAA P10253 1/20 0.48
SI P14410 1/20 0.48
MGAM2 Q2M2H8 1/20 0.48
CYP4F2 P78329 2/20 0.46
CYP4A11 Q02928 2/20 0.46
LMNA P02545 3/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 4/20 0.40
CYP2D6 P10635 1/20 0.40
ALOX15 P16050 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 2/20 0.39
TET2 Q6N021 1/20 0.39
MEN1 O00255 1/20 0.39
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL869080 1.00 TSHR (0.53) TSHRHSD17B10MGAMGAASI
SCHEMBL869082 1.00 TSHR (0.53) TSHRHSD17B10MGAMGAASI
SCHEMBL820772 0.92 CYP4F2 (0.46) TSHRHSD17B10MGAMGAASI
SCHEMBL11335823 0.92 TSHR (0.46) TSHRHSD17B10MGAMGAASI
SCHEMBL11598060 0.89
SCHEMBL9245608 0.89
SCHEMBL2427567 0.89 ALDH1A1 (0.60) TSHRHSD17B10MGAMGAASI
SCHEMBL10988428 0.89
SCHEMBL872827 0.89
SCHEMBL872828 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120742-B2 Methods of making organic compounds by metathesis ELEVANCE RENEWABLE SCIENCES, INC. (US) 2015-09-01 US disclosed
US-9079173-B2 Highly Z-selective olefins metathesis MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-07-14 US disclosed
US-20130274482-A1 HIGHLY Z-SELECTIVE OLEFINS METATHESIS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2013-10-17 US disclosed
US-8067623-B2 Producing waxes from soybean oil; ruthenium alkylidene catalytic, simultaneous opening and inserting ELEVANCE RENEWABLE SCIENCES, INC. (US) 2011-11-29 US disclosed
US-8008224-B2 Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins MATERIA, INC. (US) 2011-08-30 US disclosed
US-20090264672-A1 METHODS OF MAKING ORGANIC COMPOUNDS BY METATHESIS ELEVANCE RENEWABLE SCIENCES, INC. (US) 2009-10-22 US disclosed
US-20080064891-A1 Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like WILMAR TRADING PTE LTD (SG) 2008-03-13 US disclosed
US-20070278545-A1 Ferroelectric capacitor, method of manufacturing ferroelectric capacitor, and ferroelectric memory SEIKO EPSON CORPORATION 2007-12-06 US disclosed
US-20070282148-A1 Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins CALIFORNIA INSTITUTE OF TECHNOLOGY 2007-12-06 US disclosed
EP-1863069-A2 Ferroelectric capacitor, method of manufacturing ferroelectric capacitor, and ferroelectric memory Seiko Epson Corporation (JP) 2007-12-05 EP disclosed
US-20070054038-A1 Complex oxide laminate, method of manufacturing complex oxide laminate, and device SEIKO EPSON CORPORATION 2007-03-08 US disclosed
EP-1760770-A2 Complex oxide laminate, method of manufacturing complex oxide laminate, and device SEIKO EPSON CORPORATION (JP) 2007-03-07 EP disclosed
EP-1760768-A1 Insulating target material, method of manufacturing insulating target material, insulating complex oxide film, and devide Seiko Epson Corporation (JP) 2007-03-07 EP disclosed
US-20070045109-A1 Insulating target material, method of manufacturing insulating target material, insulating complex oxide film, and device SEIKO EPSON CORPORATION 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264672-A1 METHODS OF MAKING ORGANIC COMPOUNDS BY METATHESIS COASY, FASN, HAO2 TSHR 4683/4885HSD17B10 46/4885MGAM 1359/4885
US-20070282148-A1 Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins ORC3, OXER1, CBR3 TSHR 2215/4885HSD17B10 1888/4885MGAM 3784/4885
US-20080064891-A1 Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like SQLE, COASY, ALOX12 TSHR 4692/4885HSD17B10 173/4885MGAM 914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.